Amyloid-beta-peptide reduces the expression level of mitochondrial cytochrome oxidase subunits

Won Kyung Hong1, Eun Hae Han, Dae Ghon Kim

  • 1Biobank for Health Sciences, Center for Genome Sciences, National Institute of Health, Korea Center for Disease Control and Prevention (KCDC), 194, Tongil-Ro, Eunpyung-Ku, Seoul 122-701, Korea.

Insights

Amyloid-beta (Abeta) exposure reduces mitochondrial gene expression in human neuroblastoma cells. This suggests Abeta impairs mitochondrial function by decreasing transcription factor TFAM, contributing to neurodegenerative diseases like Alzheimer's.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondrial dysfunction is a key factor in neurological disorders, including Alzheimer's disease (AD).
  • Amyloid-beta (Abeta) peptides, implicated in AD pathogenesis, exhibit neurotoxic effects.
  • The precise mechanisms by which Abeta induces mitochondrial dysfunction remain unclear.

Purpose of the Study:

  • To investigate if amyloid-beta (Abeta) induced mitochondrial dysfunction involves alterations in cytochrome c oxidase (COX) expression.
  • To determine the effect of Abeta on mitochondrial gene expression in a human neuroblastoma cell line.

Main Methods:

  • SK-N-SH cells were exposed to varying concentrations of Abeta.
  • Messenger RNA (mRNA) levels for mitochondrial COX subunits and TFAM were quantified.
  • COX activity was measured in Abeta-treated cells.

Main Results:

  • Abeta treatment led to a significant, dose-dependent decrease in mRNA levels of mitochondrial COX subunits.
  • Abeta exposure also reduced the mRNA level of Human mitochondrial transcription factor-1 (TFAM).
  • These findings indicate Abeta modulates mitochondrial gene expression.

Conclusions:

  • Amyloid-beta (Abeta) significantly downregulates the expression of mitochondrial genes, including those for cytochrome c oxidase (COX).
  • The observed decrease in TFAM mRNA suggests that Abeta impairs mitochondrial gene expression via reduced TFAM levels.
  • This study provides insight into the molecular mechanisms linking Abeta toxicity to mitochondrial dysfunction in the context of Alzheimer's disease.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...